CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ubidecarenone

辅酶Q10 杂质对照品Ubidecarenone Impurities

EP21 个杂质条目21 impurity entries

本页汇总 辅酶Q10 的 21 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 21 impurity reference standards of Ubidecarenone with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 辅酶Q10(Ubidecarenone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesPhotostability of solid-state ubidecarenone at ordinary and elevated temperatures under exaggerated UV irradiation
    Journal of pharmaceutical sciences · 1983 · Matsuda Y, Masahara R  ·  PMID 6644572  ·  DOI
  2. 分析方法Analytical MethodsAnalysis of ubidecarenone (CoQ10) aqueous samples using reversed phase liquid chromatography
    Die Pharmazie · 2001 · Nazzal S et al.  ·  PMID 11400555
  3. 分析方法Analytical MethodsDetermination of ubidecarenone by high performance liquid chromatography
    Die Pharmazie · 1987 · Al-Shora HI  ·  PMID 3575403

辅酶Q10 —— 原料药与杂质对照品Ubidecarenone — drug substance & impurities

共 22 个条目(含原料药本体)22 items incl. the drug substance
Ubidecarenone (Coenzyme Q10) structure
EP原料药 APIAPI
辅酶Q10Ubidecarenone (Coenzyme Q10)
Ubidecarenone (Coenzyme Q10)
CAS No.303-98-0
Chemical FormulaC59H90O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 1 (Ubidecarenone EP Impurity A) structure
EPA
辅酶Q10杂质1(辅酶Q10EP杂质A)Ubidecarenone Impurity 1 (Ubidecarenone EP Impurity A)
Ubidecarenone Impurity 1 (Ubidecarenone EP Impurity A)
CAS No.3066-90-8
Chemical FormulaC9H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 2 (Ubidecarenone EP Impurity B) structure
EPB
辅酶Q10杂质2(辅酶Q10EP杂质B)Ubidecarenone Impurity 2 (Ubidecarenone EP Impurity B)
Ubidecarenone Impurity 2 (Ubidecarenone EP Impurity B)
CAS No.303-95-7
Chemical FormulaC44H66O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 3 (Ubidecarenone EP Impurity C) structure
EPC
辅酶Q10杂质3(辅酶Q10EP杂质C)Ubidecarenone Impurity 3 (Ubidecarenone EP Impurity C)
Ubidecarenone Impurity 3 (Ubidecarenone EP Impurity C)
CAS No.2394-68-5
Chemical FormulaC49H74O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 4 (Ubidecarenone EP Impurity D) structure
EPD
辅酶Q10杂质4(辅酶Q10 EP杂质D)Ubidecarenone Impurity 4 (Ubidecarenone EP Impurity D)
Ubidecarenone Impurity 4 (Ubidecarenone EP Impurity D)
CAS No.303-97-9
Chemical FormulaC54H82O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 5 (Ubidecarenone EP Impurity E)(Ubicromenol) structure
EPE
辅酶Q10杂质5(辅酶Q10EP杂质E)Ubidecarenone Impurity 5 (Ubidecarenone EP Impurity E)(Ubicromenol)
Ubidecarenone Impurity 5 (Ubidecarenone EP Impurity E)(Ubicromenol)
CAS No.65085-30-5
Chemical FormulaC59H90O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 6 (Ubidecarenone EP Impurity F) structure
EPF
辅酶Q10杂质6(辅酶Q10EP杂质F)Ubidecarenone Impurity 6 (Ubidecarenone EP Impurity F)
Ubidecarenone Impurity 6 (Ubidecarenone EP Impurity F)
CAS No.65085-29-2
Chemical FormulaC59H90O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 7 structure
7
辅酶Q10杂质7Ubidecarenone Impurity 7
Ubidecarenone Impurity 7
CAS No.24663-35-2
Chemical FormulaC64H98O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 8 (Dihydrocoenzyme Q10) structure
8
辅酶Q10杂质8 (二氢辅酶Q10)Ubidecarenone Impurity 8 (Dihydrocoenzyme Q10)
Ubidecarenone Impurity 8 (Dihydrocoenzyme Q10)
CAS No.992-78-9
Chemical FormulaC59H92O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 10 structure
10
辅酶Q10杂质10Ubidecarenone Impurity 10
Ubidecarenone Impurity 10
CAS No.2538402-20-7
Chemical FormulaC60H92O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 11 structure
11
辅酶Q10杂质11Ubidecarenone Impurity 11
Ubidecarenone Impurity 11
CAS No.2538537-69-6
Chemical FormulaC60H92O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 12 (Solanesol) structure
12
辅酶Q10杂质12(茄尼醇)Ubidecarenone Impurity 12 (Solanesol)
Ubidecarenone Impurity 12 (Solanesol)
CAS No.13190-97-1
Chemical FormulaC45H74O
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 13 (Coenzyme Q2) structure
13
辅酶Q10杂质13(辅酶 Q2)Ubidecarenone Impurity 13 (Coenzyme Q2)
Ubidecarenone Impurity 13 (Coenzyme Q2)
CAS No.606-06-4
Chemical FormulaC19H26O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 14 (Coenzyme Q4) structure
14
辅酶Q10杂质14 (辅酶Q4)Ubidecarenone Impurity 14 (Coenzyme Q4)
Ubidecarenone Impurity 14 (Coenzyme Q4)
CAS No.4370-62-1
Chemical FormulaC29H42O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 15 (Coenzyme Q6) structure
15
辅酶Q10杂质15(辅酶 Q6)Ubidecarenone Impurity 15 (Coenzyme Q6)
Ubidecarenone Impurity 15 (Coenzyme Q6)
CAS No.1065-31-2
Chemical FormulaC39H58O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 18 structure
18
辅酶Q10杂质18Ubidecarenone Impurity 18
Ubidecarenone Impurity 18
CAS No.2006296-15-5
Chemical FormulaC58H88O3
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 19 structure
19
辅酶Q10杂质19Ubidecarenone Impurity 19
Ubidecarenone Impurity 19
CAS No.2382-48-1
Chemical FormulaC59H90O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 20 structure
20
辅酶Q10杂质20Ubidecarenone Impurity 20
Ubidecarenone Impurity 20
CAS No.1173-76-8
Chemical FormulaC24H34O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 21 structure
21
辅酶Q10杂质21Ubidecarenone Impurity 21
Ubidecarenone Impurity 21
CAS No.5677-54-3
Chemical FormulaC54H84O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 25 (Mixture of E/Z-isomers) structure
25
辅酶Q10杂质25 (混合E/Z构型)Ubidecarenone Impurity 25 (Mixture of E/Z-isomers)
Ubidecarenone Impurity 25 (Mixture of E/Z-isomers)
CAS No.7200-27-3
Chemical FormulaC58H88O3
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 26 (Mixture of E/Z-isomers) structure
26
辅酶Q10杂质26 (混合E/Z构型)Ubidecarenone Impurity 26 (Mixture of E/Z-isomers)
Ubidecarenone Impurity 26 (Mixture of E/Z-isomers)
CAS No.28527-66-4
Chemical FormulaC60H92O4
Purity>95%询价On request
10mg25mg50mg100mg
Ubidecarenone Impurity 28 (Ubiquinones) structure
28
辅酶Q10杂质28 (泛醌)Ubidecarenone Impurity 28 (Ubiquinones)
Ubidecarenone Impurity 28 (Ubiquinones)
CAS No.1339-63-5
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

辅酶Q10 —— 研究文献与合成路线Ubidecarenone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 辅酶Q10 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ubidecarenone. Titles link to the original records; copyright remains with the authors and publishers.

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR PREPARING UBIDECARENONE-CONTAINING SOLID DISPERSION
    SHIM CHANG KOO, CHOI MIN KOO, LEE JI MIN · 公开号 KR20100008506KR20100008506 · 2010
  2. A SOLUBILIZED MATERIAL COMPRISING UBIDECARENONE, AQUEOUS SOLUTION AND PROCESS FOR PREPARATION THEREOF
    KIM Ji Sun, CHO Dong Hyun, SHIN Hyoung Goo, KIM Tae Wan, et al. · 公开号 WO2007032643WO2007032643 · 2007
  3. UBIDECARENONE PREPARATION
    YAMAGUCHI HIROAKI, YAMAGUCHI RUMI, NANBU HIRONOBU, REKA RAJU JUNEJA, et al. · 公开号 JP2004261005JP2004261005 · 2004
  4. A SOLUBLIZED MATERIAL COMPRISING UBIDECARENONE, AQUEOUS SOLUTION AND PROCESS FOR PREPARATION THEREOF
    — · 公开号 KR100754953BKR100754953B · 2007
  5. METHOD FOR PRODUCING WATER-SOLUBLE PREPARATION OF UBIDECARENONE COMPOUND
    TANAKA HIROAKI, HORIE MASAHIKO, KASHIWAGI KUNIAKI · 公开号 JP2004115490JP2004115490 · 2004

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

辅酶Q10 杂质谱研究要点Ubidecarenone — impurity profiling notes

下面这些是拿到 辅酶Q10 的 22 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 22 impurity entries for Ubidecarenone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances